These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34120224)

  • 41. Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy.
    Fernandez-Gonzalez S; Falo C; Pla MJ; Verdaguer P; Nuñez D; Guma A; Soler T; Vethencourt A; Vázquez S; Fernandez-Montoli ME; Campos M; Pernas S; Gil M; Ponce J; Garcia-Tejedor A
    Breast J; 2020 May; 26(5):888-896. PubMed ID: 32052521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Axillary ultrasound and Fine-Needle Aspiration Cytology in the preoperative staging of axillary node metastasis in breast cancer patients.
    Gipponi M; Fregatti P; Garlaschi A; Murelli F; Margarino C; Depaoli F; Baccini P; Gallo M; Friedman D
    Breast; 2016 Dec; 30():146-150. PubMed ID: 27728855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden.
    Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
    Breast; 2020 Oct; 53():33-41. PubMed ID: 32563178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis.
    Diepstraten SC; Sever AR; Buckens CF; Veldhuis WB; van Dalen T; van den Bosch MA; Mali WP; Verkooijen HM
    Ann Surg Oncol; 2014 Jan; 21(1):51-9. PubMed ID: 24008555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.
    Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
    Cancer Causes Control; 2021 Mar; 32(3):251-260. PubMed ID: 33377172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer.
    Assing MA; Patel BK; Karamsadkar N; Weinfurtner J; Usmani O; Kiluk JV; Drukteinis JS
    Breast J; 2017 Nov; 23(6):647-655. PubMed ID: 28397344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
    Ueda S; Tsuda H; Asakawa H; Omata J; Fukatsu K; Kondo N; Kondo T; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
    BMC Cancer; 2008 Jun; 8():165. PubMed ID: 18541009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.
    Vriens BEPJ; Keymeulen KBMI; Kroep JR; Charehbili A; Peer PG; de Boer M; Aarts MJB; Heuts EM; Tjan-Heijnen VCG;
    Oncotarget; 2017 Jul; 8(28):46557-46564. PubMed ID: 28177921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla.
    Hackney L; Williams S; Bajwa S; Morley-Davies AJ; Kirby RM; Britton I
    Breast J; 2013; 19(1):49-55. PubMed ID: 23186153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected].
    Bevilacqua J; Cody H; MacDonald KA; Tan LK; Borgen PI; Van Zee KJ
    Eur J Surg Oncol; 2002 Aug; 28(5):490-500. PubMed ID: 12217300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of preoperative axillary ultrasonography in T1 breast tumours.
    del Riego J; Diaz-Ruiz MJ; Teixidó M; Ribé J; Vilagran M; Canales L; Sentís M;
    Eur Radiol; 2016 Apr; 26(4):1073-81. PubMed ID: 26162580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast cancer subtypes affect the ultrasound performance for axillary lymph node status evaluation after neoadjuvant chemotherapy: a retrospective analysis.
    Fei J; Wang GQ; Meng YY; Zhong X; Ma JZ; Sun NN; Chen JJ
    Jpn J Clin Oncol; 2021 Oct; 51(10):1509-1514. PubMed ID: 34345909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.
    Candelaria RP; Adrada BE; Hess K; Santiago L; Lane DL; Thompson AM; Moulder SL; Huang ML; Arribas EM; Rauch GM; Leung JWT; Symmans WF; Valero V; Ravenberg EE; White JB; Yang WT
    Eur J Radiol; 2020 Sep; 130():109170. PubMed ID: 32777736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases.
    Xiong J; Zuo W; Wu Y; Wang X; Li W; Wang Q; Zhou H; Xie M; Qin X
    BMC Cancer; 2022 Nov; 22(1):1155. PubMed ID: 36352378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The SAVE review: sonographic analysis versus excision for axillary staging in breast cancer.
    Henry-Tillman R; Glover-Collins K; Preston M; Gallagher K; Tummel E; Robertson YV; Ochoa D; Korourian S; Westbrook K; Klimberg VS
    J Am Coll Surg; 2015 Apr; 220(4):560-7. PubMed ID: 25797740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study.
    Chin K; Landén AH; Kovács A; Wärnberg F; Ekholm M; Karlsson P; Olofsson Bagge R
    Breast Cancer Res Treat; 2024 Aug; 207(1):49-63. PubMed ID: 38703286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
    Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
    Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.
    Pislar N; Gasljevic G; Music MM; Borstnar S; Zgajnar J; Perhavec A
    World J Surg Oncol; 2023 Sep; 21(1):292. PubMed ID: 37715188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients.
    Riedel F; Schaefgen B; Sinn HP; Feisst M; Hennigs A; Hug S; Binnig A; Gomez C; Harcos A; Stieber A; Kauczor HU; Sohn C; Golatta M; Glaeser A; Heil J
    Eur J Radiol; 2021 Feb; 135():109468. PubMed ID: 33338758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy?
    Cortina CS; Gottschalk N; Kulkarni SA; Karst I
    J Surg Res; 2021 Jan; 257():412-418. PubMed ID: 32892139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.